Clinical trial
An Open-Label Randomized Study of Propafenone in the Treatment of Atrial Fibrillation
NCT03674658 is registered in ClinicalTrials.gov with TSH Biopharm Corporation Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Randomized Study of Propafenone in the Treatment of Atrial Fibrillation
- Lead sponsor
- TSH Biopharm Corporation Limited
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 11, 2019
- Completion date
- August 17, 2021
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.